Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 16, 2015; 3(12): 1000-1004
Published online Dec 16, 2015. doi: 10.12998/wjcc.v3.i12.1000
Published online Dec 16, 2015. doi: 10.12998/wjcc.v3.i12.1000
Colovesical fistula caused by glucocorticoid therapy for IgG4-related intrapelvic mass
Yohei Yabuuchi, Hiroyuki Matsubayashi, Hiroyuki Ono, Division of Endoscopy, Shizuoka Cancer Center, Suntogun, Shizuoka 411-8777, Japan
Masato Matsuzaki, Division of Urology, Shizuoka Cancer Center, Suntogun, Shizuoka 411-8777, Japan
Akio Shiomi, Division of Colon Surgery, Shizuoka Cancer Center, Suntogun, Shizuoka 411-8777, Japan
Michihisa Moriguchi, Division of Intervention Radiology, Shizuoka Cancer Center, Suntogun, Shizuoka 411-8777, Japan
Ichiro Kawamura, Division of Infectious Diseases, Shizuoka Cancer Center, Suntogun, Shizuoka 411-8777, Japan
Ichiro Ito, Division of Pathology, Shizuoka Cancer Center, Suntogun, Shizuoka 411-8777, Japan
Author contributions: Yabuuchi Y and Matsubayashi H participated in writing the case report and revising the draft; Matsubayashi H, Matsuzaki M, Shiomi A, Moriguchi M and Kawamura I were engaged in his treatment; Ito I helped in the pathological diagnosis; Ono H helped to supervise and approve the final manuscript.
Institutional review board statement: Institutional Review Board of Shizuoka Cancer Center ethically approved current case report (Institutional code number: 25-J123-25-1-3).
Informed consent statement: The patient provided informed written consent prior to this study.
Conflict-of-interest statement: All authors disclose no conflict.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Hiroyuki Matsubayashi, MD, PhD, Chief, Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi, Suntogun, Shizuoka 411-8777, Japan. h.matsubayashi@scchr.jp
Telephone: +81-55-9895222 Fax: +81-55-9895783
Received: July 6, 2015
Peer-review started: July 7, 2015
First decision: July 29, 2015
Revised: August 19, 2015
Accepted: October 12, 2015
Article in press: October 13, 2015
Published online: December 16, 2015
Peer-review started: July 7, 2015
First decision: July 29, 2015
Revised: August 19, 2015
Accepted: October 12, 2015
Article in press: October 13, 2015
Published online: December 16, 2015
Core Tip
Core tip: IgG4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory condition that is effectively treated with glucocorticoids. Progression of this disease may cause serious complications or several symptoms; hence, glucocorticoid therapy is often inevitable. To date, critical adverse events caused by steroid treatment for IgG4-RD have seldom been reported. The current case report describes a rare, but severe, adverse event of colovesical fistula following a good response to glucocorticoids.